Wenshu Chen

3.0k citations
82 papers · 2.3k indexed · h-index 27
Topics
Cell death mechanisms and regulation (8 papers)NF-κB Signaling Pathways (7 papers)MicroRNA in disease regulation (7 papers)
Partner nations
ChinaUnited StatesTaiwan

In The Last Decade

Wenshu Chen

75 papers receiving 2.3k citations

Peers

Wenshu Chen
Comparison fields: 5 of 123
  • Molecular Biology 1.2k
  • Immunology 634
  • Cancer Research 540
  • Oncology 350
  • Epidemiology 320
Replace Jiawei Chen with:
Jiawei Chen China
M. Ruhul Abid United States
Young Do Yoo South Korea
Yueshui Zhao China
Le Su China
Jawed A. Siddiqui United States
Guifang Yan China
Xiaoli Li China
Jonathan C. Choy Canada
Venkateshwar G. Keshamouni United States
Wenshu Chen relative to Jiawei Chen China Jiawei Chen's profile →
Citations per field
00.5×1.5×1.9×
Jiawei Chen · 1×
Citations per year

Countries citing papers authored by Wenshu Chen

Since Specialization
Citations

This map shows the geographic impact of Wenshu Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenshu Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenshu Chen more than expected).

Fields of papers citing papers by Wenshu Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenshu Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenshu Chen. The network helps show where Wenshu Chen may publish in the future.

Co-authorship network of co-authors of Wenshu Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Wenshu Chen. A scholar is included among the top collaborators of Wenshu Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenshu Chen. Wenshu Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 6
2 0
3 0
4 10
5 3
6 0
7 42
8 2
9 5
10 1
11 14
12 16
13 7
14 40
15 50
16
Optimization on the Culture Conditions of Ustilaginoidea virens(Cooke) Tak
2
17 66
18 113
19 31
20 18

About Wenshu Chen

Wenshu Chen is a scholar working on Cancer Research, Toxicology and Biochemistry, having authored 82 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (8 papers), NF-κB Signaling Pathways (7 papers) and MicroRNA in disease regulation (7 papers). The work is most often cited by research in Cancer Research (540 citations), Immunology (634 citations) and Biochemistry (126 citations). Wenshu Chen has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Yong Lin, Lang Bai, Norbert Leitinger, Poonam Sharma, Alexandra Kadl, Steven A. Belinsky, Yong Lin, Akshaya K. Meher, Xia Wang and Jenny E. Han. Their work appears in journals such as Advanced Materials, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026